A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2011
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274699 ANTIBODIES THAT BIND HUMAN PROTEIN TYROSINE PHOSPHATASE beta (HPTPbeta) AND USES THEREOF
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274697 Novel uses
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274694 ERK1/2 Posphorylation Site Specific Antibody
11/10/2011	US20110274691 Ferroportin antibodies and methods of use
11/10/2011	US20110274690 Compositions and methods for the diagnosis and treatment of tumor
11/10/2011	US20110274688 Prevention of tumors with monoclonal antibodies against neu
11/10/2011	US20110274686 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
11/10/2011	US20110274683 Antibodies That Bind CSF1R
11/10/2011	US20110274682 Methods for protease assisted protein delivery
11/10/2011	US20110274675 Therapeutically Useful Molecules
11/10/2011	US20110274671 Human progenitor t-cells
11/10/2011	US20110274670 Mesenchymal stem cells which express human hepatic growth factor,manufacturing method thereof, and use thereof as therapeutic agent for liver diseases
11/10/2011	US20110274661 Attentuated Herpesvirus Encoding a Mek Pathway Polypeptide
11/10/2011	US20110274658 Chimeric activators: quantitatively designed protein therapeutics and uses thereof
11/10/2011	US20110274657 Oxadiazole derivatives as s1p1 receptor antagonists
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274649 T-cell vaccination with viral vectors via mechanical epidermal disruption
11/10/2011	US20110274638 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274619 Brain tumor targeting peptides and methods
11/10/2011	US20110274618 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/10/2011	CA2800998A1 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
11/10/2011	CA2798616A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	CA2797842A1 Immunogenic compositions and methods for treating neoplasia
11/10/2011	CA2793544A1 Compositions and methods for the diagnosis and treatment of tumor
11/09/2011	EP2385139A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385138A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385137A1 Polymorphisms for predicting disease and treatment outcome
11/09/2011	EP2385123A1 MicroRNA molecules
11/09/2011	EP2385122A1 MicroRNA molecules
11/09/2011	EP2385117A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
11/09/2011	EP2385114A1 Diagnosis of treatment of cancer using anti-tm4sf20 antibody
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP2385058A1 Method for detecting the expression of a human endogenous retrovirus envelope protein and uses of a coding gene for said protein
11/09/2011	EP2385049A1 Sulfated c-glycoside, method for isolating same and method for synthesizing same
11/09/2011	EP2385042A1 Prokineticin 1 receptor antagonists
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385038A1 Dimeric IAP inhibitors
11/09/2011	EP2385035A1 Preparation method of dihydroindene amide compounds their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384791A2 Method and composition for treating mucosal disorders
11/09/2011	EP2384790A2 Method and composition for treating mucosal disorders
11/09/2011	EP2384766A1 Novel antibody to a carbonic anhydrase
11/09/2011	EP2384763A1 A peptide ligand to impair cancer cell migration
11/09/2011	EP2384762A1 Use of an extract obtained from plants of the family Canellaceae in the treatment of cancer
11/09/2011	EP2384752A1 Combination preparation comprising a phosphodiesterase inhibitor and a COX inhibitor for treating cancer
11/09/2011	EP2384119A1 Pharmaceutical composition comprising racemic aminopterin
11/09/2011	EP2384115A1 Methods and compositions for treating hematological malignancies
11/09/2011	EP2066647B1 Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors
11/09/2011	EP2054418B1 Dihydrothieno pyrimidines as akt protein kinase inhibitors
11/09/2011	EP2018383B1 Triazolopyrazine derivatives useful as anti-cancer agents
11/09/2011	EP1976531B1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
11/09/2011	EP1899330B9 Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect
11/09/2011	EP1794141B1 Substituted chroman derivatives, medicaments and use in therapy
11/09/2011	EP1789390B1 Pyridyl inhibitors of hedgehog signalling
11/09/2011	EP1773452B1 Lysis / resealing process for incorporating an active ingredient in erythrocytes
11/09/2011	EP1713511B1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
11/09/2011	EP1689405B1 Thioridazine and derivatives thereof for reversing anti-microbial drug-resistance
11/09/2011	EP1673085B1 C-met modulators and methods of use
11/09/2011	EP1658263B9 Novel aminobenzophenone compounds
11/09/2011	EP1526862B1 Simmondsin for use as an angiogenesis inhibitor
11/09/2011	EP1383516B1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/09/2011	EP1370539B1 Hiv inhibiting n-aminoimidazole derivatives
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	CN1931219B Gynostemma pentaphylla micro emulsion medicine and its preparation
11/09/2011	CN1248288B Nuclear transfer with differentiated fetal and adult donor cells
11/09/2011	CN102239178A Inhibition of plgf to treat philadelphia chromosome positive leukemia
11/09/2011	CN102239171A Kinase inhibitors with improved cyp safety profile
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239149A Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
11/09/2011	CN102239138A Auto magnetic metal salen complex compound
11/09/2011	CN102238967A Telomerase inhibitors and methods of use thereof
11/09/2011	CN102234687A Application of micro ribose nucleic acid (miRNA) or precursor thereof of inhibitor zinc finger protein Zinc finger and BTBdomain-containing protein 20 (ZBTB20)
11/09/2011	CN102234658A Target quaternary ammonium salt cationic polymer lipid gene carrier, preparation method and application thereof
11/09/2011	CN102234376A Preparation and application of tubulin ligand affinity material
11/09/2011	CN102234314A Method for preparing a group of snake venom derived active peptides and application of active peptides in anti-tumor aspect
11/09/2011	CN102234295A Platinum (II) complex adopting N-alkyl substituted trans 1,2-diaminocyclohexane as ligand and preparation method thereof
11/09/2011	CN102234286A Condensed heteroaryl derivatives
11/09/2011	CN102234283A 4'-demethyl epipodophyllotoxin derivatives, and synthesis method and application thereof
11/09/2011	CN102234271A Aryl (alkyl) amino dithio formate compounds, and preparation method and application thereof
11/09/2011	CN102234270A Diarylurea derivatives and treatment application thereof
11/09/2011	CN102234266A Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure
11/09/2011	CN102234262A Method for preparing caffeic acid hydroxycoumarin ester compounds
11/09/2011	CN102234259A Sphaelactone derivatives, their pharmaceutical compositions, preparation method thereof and application thereof
11/09/2011	CN102234258A Preparation method and application of sphaelactone
11/09/2011	CN102234254A Benzisoselenazol compounds, and preparation method and application thereof
11/09/2011	CN102234250A Antitumor bioactive alkaloid compound in Agelas clathrodes
11/09/2011	CN102234232A Jiangxi ketene ester and application thereof
11/09/2011	CN102233134A Slit-Robo-mediated lymph vessel formation and application
11/09/2011	CN102233120A Medicament for treating tumor
11/09/2011	CN102233117A Traditional Chinese medicine composition for resisting stomach cancer metastasis
11/09/2011	CN102233104A Chinese medicine for treating nasopharyngeal carcinoma
11/09/2011	CN102233083A Traditional Chinese medicine for treating nasopharyngeal carcinoma diseases
11/09/2011	CN102233072A Traditional Chinese medicine pill for treating tumors
11/09/2011	CN102233068A Method for preparing total saponin of roots of Japanese bananas

1 ... 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 ... 2211